The Medtech Sector
Strategic Support for Medtech SMEs: Marketing, Innovation, and Market Access
In a B2B environment undergoing rapid digital transformation, medtech SMEs face complex challenges involving regulation, innovation, and business development. Maia Consulting supports these innovative companies with expertise and solutions tailored to their real-world circumstances.
Our support covers the key pillars of their success: a clear and distinctive strategic positioning, evidence-based communication (KOLs, targeted publications), and a structured approach to market access (MDR compliance, digital strategy, AI, go-to-market).
Our expert consultants in Medtech digital marketing also address cross-functional priorities for B2B SMEs: digital transformation in compliance with regulatory requirements (GDPR, MDR), marketing automation tailored to long sales cycles, the creation of educational content, and marketing-sales alignment to support field teams. Maia Consulting thus enables its clients to harness the full potential of B2B e-commerce, enhance personalization through AI, and effectively build customer loyalty through measurable strategies.
Our mission: to offer medtech SMEs a personalized, sustainable, and results-oriented approach that enables them to leverage technological innovations while complying with healthcare industry requirements.
Our MedTech support includes
Strategy & Positioning
- In-depth analysis of your market and identification of your competitive advantage.
- A precise definition of buyer personas and ICP (Ideal Customer Profile).
- Formulating a clear and distinctive Unique Value Proposition (UVP) to maximize buy-in from investors and hospital stakeholders.
360° Communication & Influence
- Developing a communication strategy based on concrete evidence.
- Engaging Key Opinion Leaders (KOLs), targeted publications, and a strategic presence on relevant channels to strengthen your credibility and brand awareness among healthcare professionals.
- Investor communications: scientific storytelling, market-oriented messaging, and a pitch deck designed to meet the expectations of specialized healthcare and medtech funds.
Go-to-Market & Market Access
- Developing a clear roadmap to accelerate time to market: regulatory compliance (MDR), economic value creation, digital levers, and the use of artificial intelligence.
- Precise targeting of geographic markets, optimized sales activation, and post-launch growth for immediate and sustainable results.
Medtech Expert Committee
Our mission: to provide personalized, immediately actionable support to medtech companies by combining a differentiation strategy, scientific credibility, and market performance.
We also draw on acommittee of life sciences experts, which enriches our strategic thinking and helps us identify and engage key opinion leaders (KOLs) in the sector.
Finally, we have a large network of freelance experts specializing in medtech who are ready to be called upon ; we mobilize them on demand to address your specific challenges with agility, precision, and efficiency.
Members of our Life Sciences Expert Committee
Olivier Decuypere
Experienced executive in the MedTech sector, with over 20 years of experience in Europe and emerging markets. Strong track record in strategic management, business leadership, and marketing. Passionate about developing high-impact teams, innovation, and value-driven strategies. Experience in various therapeutic areas, including general surgery (colorectal, bariatric), urogynecology, orthopedics, cardiology, and the management of intraoperative bleeding.
Pierre-François Migeotte
As a physicist (PhD) turned entrepreneur, I founded and led HeartKinetics, a MedTech spin-off specializing in cardiac telemonitoring, from the initial idea through clinical trials and international partnerships. The result: over €4 million raised, a connected solution validated by the Mayo Clinic, and a journey at the heart of medical innovation.
Since then, I’ve been supporting high-potential projects in health technology: proof of concept, market access strategy, fundraising, regulatory filings, and investor pitches. My motto: turning science into impact—no bullshit, but with method, networking, and commitment.
I’m joining the Life Sciences Committee to share this hands-on experience and help entrepreneurs gain momentum, credibility, and tangible results.
Denis Dufrane
A pioneer in regenerative medicine, Denis Dufrane is the CEO and founder of Novadip Biosciences, a Belgian biotech company at the forefront of 3D therapies for bone and skin regeneration. With a career at the intersection of translational research and entrepreneurship, he has transformed discoveries in stem cell and tissue engineering into innovative clinical solutions, particularly for severe burns and complex bone defects.
They trust us
